{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:52:01Z","timestamp":1790985121831,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030-172978"],"award-info":[{"award-number":["310030-172978"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["NRP78 Implementation Programme"],"award-info":[{"award-number":["NRP78 Implementation Programme"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["NRP78 Implementation Programme"],"award-info":[{"award-number":["NRP78 Implementation Programme"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008485","name":"Schweizerische Akademie der Medizinischen Wissenschaften","doi-asserted-by":"publisher","award":["323530-191230"],"award-info":[{"award-number":["323530-191230"]}],"id":[{"id":"10.13039\/501100008485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008485","name":"Schweizerische Akademie der Medizinischen Wissenschaften","doi-asserted-by":"publisher","award":["323530-177975"],"award-info":[{"award-number":["323530-177975"]}],"id":[{"id":"10.13039\/501100008485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008485","name":"Schweizerische Akademie der Medizinischen Wissenschaften","doi-asserted-by":"publisher","award":["323530-191220"],"award-info":[{"award-number":["323530-191220"]}],"id":[{"id":"10.13039\/501100008485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008485","name":"Schweizerische Akademie der Medizinischen Wissenschaften","doi-asserted-by":"publisher","award":["Talents in Clinical Research Project Grant (YTCR 08\/20)"],"award-info":[{"award-number":["Talents in Clinical Research Project Grant (YTCR 08\/20)"]}],"id":[{"id":"10.13039\/501100008485","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Acute viral infections are usually cleared by an efficient anti-pathogen immune response, following which immune homeostasis is restored. Occasionally, such pathogen-induced immune response fails to abate despite clinical recovery, but how this occurs in humans has not been thoroughly investigated. Here, we perform a detailed analysis of T cell homeostasis following\u00a0severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, which reveals persistent activation and dyshomeostasis of CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells for 6\u201312 months after acute infection. Compared to steady-state and unlike T cell responses following vaccination, interleukin (IL)\u22122 receptor and IL-7 receptor expression remains altered on both SARS-CoV-2-specific and bystander T cells for 6\u201312 months after acute infection. These alterations correlate with increased IL-7 and IL-15 serum levels and are reproduced by in vitro stimulation by IL-7 and IL-15, but surprisingly not by IL-2. Collectively, our study demonstrates prolonged T cell dyshomeostasis driven by dysregulated homeostatic cytokine signals following acute viral infection.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-66753-1","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T14:34:43Z","timestamp":1764254083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dysregulation of homeostatic cytokine receptors drives prolonged T cell activation following acute SARS-CoV-2 infection in humans"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7117-0335","authenticated-orcid":false,"given":"Laura","family":"Ceglarek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0522-7629","authenticated-orcid":false,"given":"Patrick","family":"Taeschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7671-7570","authenticated-orcid":false,"given":"Alp","family":"Inci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5387-9950","authenticated-orcid":false,"given":"Yves","family":"Zurbuchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cervia-Hasler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-0246","authenticated-orcid":false,"given":"Miro E.","family":"Raeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8279-5545","authenticated-orcid":false,"given":"Onur","family":"Boyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"66753_CR1","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","volume":"50","author":"WJ Leonard","year":"2019","unstructured":"Leonard, W. J., Lin, J.-X. & O\u2019Shea, J. J. The \u03b3c family of cytokines: basic biology to therapeutic ramifications. Immunity 50, 832\u2013850 (2019).","journal-title":"Immunity"},{"key":"66753_CR2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.immuni.2008.11.002","volume":"29","author":"CD Surh","year":"2008","unstructured":"Surh, C. D. & Sprent, J. Homeostasis of naive and memory T cells. Immunity 29, 848\u2013862 (2008).","journal-title":"Immunity"},{"key":"66753_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/imr.12644","volume":"283","author":"ME Raeber","year":"2018","unstructured":"Raeber, M. E., Zurbuchen, Y., Impellizzieri, D. & Boyman, O. The role of cytokines in T-cell memory in health and disease. Immunol. Rev. 283, 176\u2013193 (2018).","journal-title":"Immunol. Rev."},{"key":"66753_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"O Boyman","year":"2012","unstructured":"Boyman, O. & Sprent, J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12, 180\u2013190 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"66753_CR5","doi-asserted-by":"publisher","unstructured":"Nguyen, T. A. N. et al. Real-time visualization of STAT activation in live cells using genetically encoded biosensors. Nat. Chem. Biol. https:\/\/doi.org\/10.1038\/s41589-025-02012-0 (2025).","DOI":"10.1038\/s41589-025-02012-0"},{"key":"66753_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0092-8674(93)90152-G","volume":"73","author":"T Taniguchi","year":"1993","unstructured":"Taniguchi, T. & Minami, Y. The IL-2\/IL-2 receptor system: a current overview. Cell 73, 5\u20138 (1993).","journal-title":"Cell"},{"key":"66753_CR7","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.2337\/db14-1322","volume":"64","author":"A Yu","year":"2015","unstructured":"Yu, A. et al. Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. Diabetes 64, 2172\u20132183 (2015).","journal-title":"Diabetes"},{"key":"66753_CR8","doi-asserted-by":"publisher","first-page":"eabb9283","DOI":"10.1126\/scitranslmed.abb9283","volume":"12","author":"U Karakus","year":"2020","unstructured":"Karakus, U. et al. Receptor-gated IL-2 delivery by an anti-human IL-2 antibody activates regulatory T cells in three different species. Sci. Transl. Med. 12, eabb9283 (2020).","journal-title":"Sci. Transl. Med."},{"key":"66753_CR9","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nm866","volume":"9","author":"JN Blattman","year":"2003","unstructured":"Blattman, J. N. et al. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9, 540\u2013547 (2003).","journal-title":"Nat. Med."},{"key":"66753_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.immuni.2009.11.010","volume":"32","author":"V Kalia","year":"2010","unstructured":"Kalia, V. et al. Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 32, 91\u2013103 (2010).","journal-title":"Immunity"},{"key":"66753_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1074-7613(00)80564-6","volume":"8","author":"X Zhang","year":"1998","unstructured":"Zhang, X., Sun, S., Hwang, I., Tough, D. F. & Sprent, J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8, 591\u2013599 (1998).","journal-title":"Immunity"},{"key":"66753_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1074-7613(02)00429-6","volume":"17","author":"S Dubois","year":"2002","unstructured":"Dubois, S., Mariner, J., Waldmann, T. A. & Tagaya, Y. IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity 17, 537\u2013547 (2002).","journal-title":"Immunity"},{"key":"66753_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1084\/jem.20041389","volume":"200","author":"PR Burkett","year":"2004","unstructured":"Burkett, P. R. et al. Coordinate expression and trans presentation of interleukin (IL)-15R\u03b1 and IL-15 support natural killer cell and memory CD8+ T cell homeostasis. J. Exp. Med. 200, 825 (2004).","journal-title":"J. Exp. Med."},{"key":"66753_CR14","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/jem.20071913","volume":"205","author":"E Mortier","year":"2008","unstructured":"Mortier, E., Woo, T., Advincula, R., Gozalo, S. & Ma, A. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J. Exp. Med. 205, 1213\u20131225 (2008).","journal-title":"J. Exp. Med."},{"key":"66753_CR15","doi-asserted-by":"publisher","first-page":"11906","DOI":"10.1073\/pnas.1002569107","volume":"107","author":"C Krieg","year":"2010","unstructured":"Krieg, C., L\u00e9tourneau, S., Pantaleo, G. & Boyman, O. Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells. Proc. Natl Acad. Sci. USA. 107, 11906\u201311911 (2010).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"66753_CR16","doi-asserted-by":"publisher","first-page":"367ra166","DOI":"10.1126\/scitranslmed.aag3187","volume":"8","author":"N Arenas-Ramirez","year":"2016","unstructured":"Arenas-Ramirez, N. et al. Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2. Sci. Transl. Med. 8, 367ra166 (2016).","journal-title":"Sci. Transl. Med."},{"key":"66753_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba5464","volume":"12","author":"ME Raeber","year":"2020","unstructured":"Raeber, M. E., Rosalia, R. A., Schmid, D., Karakus, U. & Boyman, O. Interleukin-2 signals converge in a lymphoid\u2013dendritic cell pathway that promotes anticancer immunity. Sci. Transl. Med. 12, eaba5464 (2020).","journal-title":"Sci. Transl. Med."},{"key":"66753_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20220-1","volume":"11","author":"D Sahin","year":"2020","unstructured":"Sahin, D. et al. An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer. Nat. Commun. 11, 6440 (2020).","journal-title":"Nat. Commun."},{"key":"66753_CR19","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/j.immuni.2024.07.016","volume":"57","author":"ME Raeber","year":"2024","unstructured":"Raeber, M. E. et al. Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics. Immunity 57, 2232\u20132250.e10 (2024).","journal-title":"Immunity"},{"key":"66753_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.smim.2012.04.010","volume":"24","author":"F Carrette","year":"2012","unstructured":"Carrette, F. & Surh, C. D. IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. Semin. Immunol. 24, 209\u2013217 (2012).","journal-title":"Semin. Immunol."},{"key":"66753_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/80868","volume":"1","author":"KS Schluns","year":"2000","unstructured":"Schluns, K. S., Kieper, W. C., Jameson, S. C. & Lefran\u00e7ois, L. Interleukin-7 mediates the homeostasis of na\u00efve and memory CD8 T cells in vivo. Nat. Immunol. 1, 426\u2013432 (2000).","journal-title":"Nat. Immunol."},{"key":"66753_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ni.2494","volume":"14","author":"MY Kimura","year":"2013","unstructured":"Kimura, M. Y. et al. IL-7 signaling must be intermittent, not continuous, during CD8+ T cell homeostasis to promote cell survival instead of cell death. Nat. Immunol. 14, 143\u2013151 (2013).","journal-title":"Nat. Immunol."},{"key":"66753_CR23","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1084\/jem.20060468","volume":"203","author":"N Seddiki","year":"2006","unstructured":"Seddiki, N. et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203, 1693\u20131700 (2006).","journal-title":"J. Exp. Med."},{"key":"66753_CR24","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","volume":"203","author":"W Liu","year":"2006","unstructured":"Liu, W. et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203, 1701\u20131711 (2006).","journal-title":"J. Exp. Med."},{"key":"66753_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2004.07.016","volume":"21","author":"J-H Park","year":"2004","unstructured":"Park, J.-H. et al. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 21, 289\u2013302 (2004).","journal-title":"Immunity"},{"key":"66753_CR26","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1084\/jem.20182304","volume":"216","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. Human interleukin-2 receptor \u03b2 mutations associated with defects in immunity and peripheral tolerance. J. Exp. Med. 216, 1311\u20131327 (2019).","journal-title":"J. Exp. Med."},{"key":"66753_CR27","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1084\/jem.20182015","volume":"216","author":"IZ Fernandez","year":"2019","unstructured":"Fernandez, I. Z. et al. A novel human IL2RB mutation results in T and NK cell\u2013driven immune dysregulation. J. Exp. Med. 216, 1255\u20131267 (2019).","journal-title":"J. Exp. Med."},{"key":"66753_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI180251","volume":"134","author":"CA Arango-Franco","year":"2024","unstructured":"Arango-Franco, C. A. et al. IL-7\u2013dependent and \u2013independent lineages of IL-7R\u2013dependent human T cells. J. Clin. Investig. 134, e180251 (2024).","journal-title":"J. Clin. Investig."},{"key":"66753_CR29","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.it.2015.10.003","volume":"36","author":"N Arenas-Ramirez","year":"2015","unstructured":"Arenas-Ramirez, N., Woytschak, J. & Boyman, O. Interleukin-2: biology, design and application. Trends Immunol. 36, 763\u2013777 (2015).","journal-title":"Trends Immunol."},{"key":"66753_CR30","doi-asserted-by":"publisher","first-page":"eabo5409","DOI":"10.1126\/scitranslmed.abo5409","volume":"14","author":"ME Raeber","year":"2022","unstructured":"Raeber, M. E., Sahin, D. & Boyman, O. Interleukin-2-based therapies in cancer. Sci. Transl. Med. 14, eabo5409 (2022).","journal-title":"Sci. Transl. Med."},{"key":"66753_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-021-04280-x","volume":"602","author":"S Adamo","year":"2022","unstructured":"Adamo, S. et al. Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection. Nature 602, 148\u2013155 (2022).","journal-title":"Nature"},{"key":"66753_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27797-1","volume":"13","author":"C Cervia","year":"2022","unstructured":"Cervia, C. et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat. Commun. 13, 446 (2022).","journal-title":"Nat. Commun."},{"key":"66753_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jaci.2020.10.040","volume":"147","author":"C Cervia","year":"2021","unstructured":"Cervia, C. et al. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. J. Allergy Clin. Immunol. 147, 545\u2013557.e9 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"66753_CR34","doi-asserted-by":"publisher","first-page":"eadg7942","DOI":"10.1126\/science.adg7942","volume":"383","author":"C Cervia-Hasler","year":"2024","unstructured":"Cervia-Hasler, C. et al. Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science 383, eadg7942 (2024).","journal-title":"Science"},{"key":"66753_CR35","doi-asserted-by":"publisher","first-page":"100166","DOI":"10.1016\/j.xcrm.2020.100166","volume":"2","author":"S Chevrier","year":"2021","unstructured":"Chevrier, S. et al. A distinct innate immune signature marks progression from mild to severe COVID-19. Cell Rep. Med. 2, 100166 (2021).","journal-title":"Cell Rep. Med."},{"key":"66753_CR36","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41590-023-01497-y","volume":"24","author":"Y Zurbuchen","year":"2023","unstructured":"Zurbuchen, Y. et al. Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2. Nat. Immunol. 24, 955\u2013965 (2023).","journal-title":"Nat. Immunol."},{"key":"66753_CR37","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1111\/all.15302","volume":"77","author":"P Taeschler","year":"2022","unstructured":"Taeschler, P. et al. Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures. Allergy 77, 2415\u20132430 (2022).","journal-title":"Allergy"},{"key":"66753_CR38","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1111\/all.15372","volume":"77","author":"P Taeschler","year":"2022","unstructured":"Taeschler, P. et al. T cell recovery and evidence of persistent immune activation 12 months after severe Covid-19. Allergy 77, 2468\u20132481 (2022).","journal-title":"Allergy"},{"key":"66753_CR39","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1111\/all.14866","volume":"76","author":"S Adamo","year":"2021","unstructured":"Adamo, S. et al. Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19. Allergy 76, 2866\u20132881 (2021).","journal-title":"Allergy"},{"key":"66753_CR40","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","volume":"30","author":"M Miyara","year":"2009","unstructured":"Miyara, M. et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30, 899\u2013911 (2009).","journal-title":"Immunity"},{"key":"66753_CR41","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli, A. et al. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126, 458\u2013465 (2009).","journal-title":"Immunology"},{"key":"66753_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adk3295","volume":"16","author":"MJ Peluso","year":"2024","unstructured":"Peluso, M. J. et al. Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection. Sci. Transl. Med. 16, eadk3295 (2024).","journal-title":"Sci. Transl. Med."},{"key":"66753_CR43","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","volume":"612","author":"SR Stein","year":"2022","unstructured":"Stein, S. R. et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758\u2013763 (2022).","journal-title":"Nature"},{"key":"66753_CR44","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1084\/jem.20020772","volume":"196","author":"AD Judge","year":"2002","unstructured":"Judge, A. D., Zhang, X., Fujii, H., Surh, C. D. & Sprent, J. Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8+ T cells. J. Exp. Med. 196, 935\u2013946 (2002).","journal-title":"J. Exp. Med."},{"key":"66753_CR45","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1084\/jem.20052495","volume":"203","author":"O Boyman","year":"2006","unstructured":"Boyman, O., Cho, J.-H., Tan, J. T., Surh, C. D. & Sprent, J. A major histocompatibility complex class I\u2013dependent subset of memory phenotype CD8+ cells. J. Exp. Med. 203, 1817\u20131825 (2006).","journal-title":"J. Exp. Med."},{"key":"66753_CR46","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41586-022-04419-4","volume":"603","author":"F Ingelfinger","year":"2022","unstructured":"Ingelfinger, F. et al. Twin study reveals non-heritable immune perturbations in multiple sclerosis. Nature 603, 152\u2013158 (2022).","journal-title":"Nature"},{"key":"66753_CR47","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41577-022-00680-w","volume":"22","author":"R Hernandez","year":"2022","unstructured":"Hernandez, R., P\u00f5der, J., LaPorte, K. M. & Malek, T. R. Engineering IL-2 for immunotherapy of autoimmunity and cancer. Nat. Rev. Immunol. 22, 614\u2013628 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"66753_CR48","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41573-023-00746-x","volume":"22","author":"WJ Leonard","year":"2023","unstructured":"Leonard, W. J. & Lin, J.-X. Strategies to therapeutically modulate cytokine action. Nat. Rev. Drug Discov. 22, 827\u2013854 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"66753_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112639","volume":"28","author":"CSM Yong","year":"2025","unstructured":"Yong, C. S. M. et al. IL-2 immunotherapy rescues irradiation-induced T cell exhaustion in mouse colon cancer. iScience 28, 112639 (2025).","journal-title":"iScience"},{"key":"66753_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2009.11.012","volume":"32","author":"ME Pipkin","year":"2010","unstructured":"Pipkin, M. E. et al. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32, 79\u201390 (2010).","journal-title":"Immunity"},{"key":"66753_CR51","doi-asserted-by":"publisher","first-page":"2000524","DOI":"10.1183\/13993003.00524-2020","volume":"55","author":"R-H Du","year":"2020","unstructured":"Du, R.-H. et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur. Respir. J. 55, 2000524 (2020).","journal-title":"Eur. Respir. J."},{"key":"66753_CR52","doi-asserted-by":"publisher","first-page":"20200","DOI":"10.1073\/pnas.1313654110","volume":"110","author":"JL Jones","year":"2013","unstructured":"Jones, J. L. et al. Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation. Proc. Natl. Acad. Sci. USA 110, 20200\u201320205 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66753_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6377","volume":"5","author":"KK McKinstry","year":"2014","unstructured":"McKinstry, K. K. et al. Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2. Nat. Commun. 5, 5377 (2014).","journal-title":"Nat. Commun."},{"key":"66753_CR54","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/ni.2079","volume":"12","author":"S Feau","year":"2011","unstructured":"Feau, S., Arens, R., Togher, S. & Schoenberger, S. P. Autocrine IL-2 is required for secondary population expansion of CD8+ memory T cells. Nat. Immunol. 12, 908\u2013913 (2011).","journal-title":"Nat. Immunol."},{"key":"66753_CR55","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.187.2.271","volume":"187","author":"O Schulz","year":"1998","unstructured":"Schulz, O., Sewell, H. F. & Shakib, F. Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. J. Exp. Med. 187, 271\u2013275 (1998).","journal-title":"J. Exp. Med."},{"key":"66753_CR56","doi-asserted-by":"publisher","first-page":"12111","DOI":"10.1073\/pnas.1714019114","volume":"114","author":"P Li","year":"2017","unstructured":"Li, P. et al. STAT5-mediated chromatin interactions in superenhancers activate IL-2 highly inducible genes: Functional dissection of the Il2ra gene locus. Proc. Natl. Acad. Sci. USA 114, 12111\u201312119 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66753_CR57","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adi8217","volume":"8","author":"R Spolski","year":"2023","unstructured":"Spolski, R. et al. Distinct use of super-enhancer elements controls cell type\u2013specific CD25 transcription and function. Sci. Immunol. 8, eadi8217 (2023).","journal-title":"Sci. Immunol."},{"key":"66753_CR58","unstructured":"WHO. COVID-19 Clinical management: living guideline (WHO, 2025)."},{"key":"66753_CR59","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg, M. C. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40, 1725\u20131725 (1997).","journal-title":"Arthritis Rheum."},{"key":"66753_CR60","doi-asserted-by":"publisher","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004 (2010).","journal-title":"PLoS ONE"},{"key":"66753_CR61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun, B. B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73\u201379 (2018).","journal-title":"Nature"},{"key":"66753_CR62","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/cyto.a.23904","volume":"97","author":"S Van Gassen","year":"2020","unstructured":"Van Gassen, S., Gaudilliere, B., Angst, M. S., Saeys, Y. & Aghaeepour, N. CytoNorm: A Normalization Algorithm for Cytometry Data. Cytom. Part J. Int. Soc. Anal. Cytol. 97, 268\u2013278 (2020).","journal-title":"Cytom. Part J. Int. Soc. Anal. Cytol."},{"key":"66753_CR63","doi-asserted-by":"crossref","unstructured":"den Braanker, H., Bongenaar, M. & Lubberts, E. How to prepare spectral flow cytometry datasets for high-dimensional data analysis: a practical workflow. Front. Immunol. 12, 768113 (2021).","DOI":"10.3389\/fimmu.2021.768113"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66753-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66753-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66753-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T05:52:47Z","timestamp":1767073967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66753-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66753"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66753-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.B. is a shareholder of Anaveon AG, which develops IL-2 immunotherapies for cancer. O.B. and M.E.R. hold patents on improved IL-2 formulations and are shareholders of Seito Biologics AG, which develops improved IL-2 immunotherapies for autoimmune diseases. The other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11693"}}